Cipher Gene secures multimillion-yuan Pre-B financing round

On July 20, Cipher Gene, a genetic testing service company focusing on children’s genetic diseases, completed a multimillion-yuan Pre-B round of financing led by CS Investment, with participation from SOVA and Everest Capital.

On July 20, Cipher Gene, a genetic testing service company focusing on children’s genetic diseases, completed a multimillion-yuan Pre-B round of financing led by CS Investment, with participation from SOVA and Everest Capital.

Proceeds from this round of financing will be used for new product development, market expansion and team expansion.

Founded in October 2015, Cipher Gene mainly provides clinical-level precision medical services focused on the niche area of childhood genetic diseases.

The company currently has a manufacturing operations center, medical testing laboratory, high-throughput drug screening research and development center, which can provide integrated products and services for clinical diagnosis and treatment.

To date, the company has established stable clinical or scientific cooperation with nearly 300 3A hospitals in China, including the Peking University First Hospital, Xiangya Hospital Central South University, The Children’s Hospital Zhejiang University School of Medicine, and Children’s Hospital of Xi’an Jiao Tong University.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/07/23/cipher-gene-secures-multimillion-yuan-pre-b-financing-round/.

Leave a Reply

Please Login to Comment